ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 65 filers reported holding ACORDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 14.66 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $65,000 | -3.0% | 94,103 | -27.2% | 0.00% | – |
| Q3 2020 | $67,000 | -30.9% | 129,331 | -2.3% | 0.00% | – |
| Q2 2020 | $97,000 | -81.6% | 132,374 | -76.5% | 0.00% | – |
| Q1 2020 | $526,000 | -73.3% | 563,767 | -41.5% | 0.00% | – |
| Q4 2019 | $1,967,000 | -32.8% | 964,115 | -5.4% | 0.00% | -100.0% |
| Q3 2019 | $2,925,000 | -61.6% | 1,019,088 | +2.6% | 0.00% | -50.0% |
| Q2 2019 | $7,618,000 | -40.7% | 993,261 | +2.7% | 0.00% | -33.3% |
| Q1 2019 | $12,854,000 | -17.8% | 967,192 | -3.7% | 0.00% | -25.0% |
| Q4 2018 | $15,641,000 | -21.4% | 1,003,918 | -0.9% | 0.00% | -20.0% |
| Q3 2018 | $19,900,000 | -33.9% | 1,012,739 | -3.5% | 0.01% | -37.5% |
| Q2 2018 | $30,127,000 | +22.2% | 1,049,729 | +0.7% | 0.01% | +33.3% |
| Q1 2018 | $24,647,000 | +10.8% | 1,042,123 | +0.5% | 0.01% | 0.0% |
| Q4 2017 | $22,244,000 | -10.7% | 1,036,983 | -1.5% | 0.01% | 0.0% |
| Q3 2017 | $24,906,000 | +40.8% | 1,053,040 | +17.3% | 0.01% | +20.0% |
| Q2 2017 | $17,690,000 | +54.9% | 897,974 | +65.2% | 0.01% | +66.7% |
| Q1 2017 | $11,417,000 | +13.9% | 543,670 | +2.0% | 0.00% | 0.0% |
| Q4 2016 | $10,021,000 | -6.5% | 533,080 | +3.8% | 0.00% | 0.0% |
| Q3 2016 | $10,721,000 | -16.4% | 513,419 | +2.1% | 0.00% | -25.0% |
| Q2 2016 | $12,830,000 | -8.3% | 502,976 | -4.9% | 0.00% | -20.0% |
| Q1 2016 | $13,993,000 | -37.2% | 528,975 | +1.5% | 0.01% | -28.6% |
| Q4 2015 | $22,296,000 | +65.4% | 521,174 | +2.5% | 0.01% | +75.0% |
| Q3 2015 | $13,479,000 | -16.0% | 508,497 | +5.6% | 0.00% | -20.0% |
| Q2 2015 | $16,048,000 | -4.0% | 481,487 | -4.1% | 0.01% | 0.0% |
| Q1 2015 | $16,708,000 | -17.3% | 502,008 | +1.6% | 0.01% | -16.7% |
| Q4 2014 | $20,197,000 | +17.0% | 494,178 | -3.0% | 0.01% | +20.0% |
| Q3 2014 | $17,268,000 | -0.0% | 509,685 | -0.5% | 0.01% | 0.0% |
| Q2 2014 | $17,269,000 | -20.2% | 512,277 | -10.3% | 0.01% | -28.6% |
| Q1 2014 | $21,647,000 | +23.3% | 571,020 | -5.0% | 0.01% | +16.7% |
| Q4 2013 | $17,555,000 | -14.0% | 601,197 | +0.7% | 0.01% | -14.3% |
| Q3 2013 | $20,414,000 | +2.3% | 596,908 | -1.4% | 0.01% | 0.0% |
| Q2 2013 | $19,963,000 | – | 605,112 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|